Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection

H. Ueno, S. Okada, T. Okusaka, M. Ikeda, N. Tanaka, Michiie Sakamoto, M. Yoshimori

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background/Aims: Some hepatocellular carcinoma nodules do not show tumor stain by hepatic angiography or enhanced computed tomography. The aim of this study was to clarify the prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. Methodology: Twenty patients who had hepatocellular carcinoma with no tumor stain were treated by percutaneous ethanol injection between January 1990 and June 1998. No patients had received any anticancer treatments before percutaneous ethanol injection. Recurrence-free survival, predictive factors for recurrence and recurrent patterns were examined. Overall survival was also examined. Results: Ten of the 20 patients showed intrahepatic recurrences in other parts of the treated lesions, although no local recurrence was observed. Median recurrence-free survival time, 1-, 3- and 5-year recurrence-free survival rates were 2.8 years, 66%, 43% and 22%, respectively. A serum alpha-fetoprotein level of 20ng/mL or less was the only factor that was significantly associated with prolonged recurrence-free survival. Of the 12 recurrent nodules in 10 patients, 9 occurred in different segments of the treated lesion and 8 were histopathologically confirmed to be well-differentiated hepatocellular carcinoma. Overall survival rates 1, 3, and 5 years after percutaneous ethanol injection were 100%, 82%, and 75%, respectively. Conclusions: Percutaneous ethanol injection may be useful for the treatment of hepatocellular carcinoma with no tumor stain.

Original languageEnglish
Pages (from-to)1430-1434
Number of pages5
JournalHepato-Gastroenterology
Volume48
Issue number41
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Hepatocellular Carcinoma
Ethanol
Coloring Agents
Recurrence
Injections
Neoplasms
Survival
Survival Rate
alpha-Fetoproteins
Angiography
Tomography
Liver
Therapeutics
Serum

Keywords

  • Hepatocellular carcinoma
  • Liver
  • Percutaneous ethanol injection
  • Prognosis
  • Tumor stain

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Ueno, H., Okada, S., Okusaka, T., Ikeda, M., Tanaka, N., Sakamoto, M., & Yoshimori, M. (2001). Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. Hepato-Gastroenterology, 48(41), 1430-1434.

Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. / Ueno, H.; Okada, S.; Okusaka, T.; Ikeda, M.; Tanaka, N.; Sakamoto, Michiie; Yoshimori, M.

In: Hepato-Gastroenterology, Vol. 48, No. 41, 2001, p. 1430-1434.

Research output: Contribution to journalArticle

Ueno, H, Okada, S, Okusaka, T, Ikeda, M, Tanaka, N, Sakamoto, M & Yoshimori, M 2001, 'Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection', Hepato-Gastroenterology, vol. 48, no. 41, pp. 1430-1434.
Ueno, H. ; Okada, S. ; Okusaka, T. ; Ikeda, M. ; Tanaka, N. ; Sakamoto, Michiie ; Yoshimori, M. / Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. In: Hepato-Gastroenterology. 2001 ; Vol. 48, No. 41. pp. 1430-1434.
@article{bcfa9ab9ecbb4f928adeff0437a1a7e5,
title = "Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection",
abstract = "Background/Aims: Some hepatocellular carcinoma nodules do not show tumor stain by hepatic angiography or enhanced computed tomography. The aim of this study was to clarify the prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. Methodology: Twenty patients who had hepatocellular carcinoma with no tumor stain were treated by percutaneous ethanol injection between January 1990 and June 1998. No patients had received any anticancer treatments before percutaneous ethanol injection. Recurrence-free survival, predictive factors for recurrence and recurrent patterns were examined. Overall survival was also examined. Results: Ten of the 20 patients showed intrahepatic recurrences in other parts of the treated lesions, although no local recurrence was observed. Median recurrence-free survival time, 1-, 3- and 5-year recurrence-free survival rates were 2.8 years, 66{\%}, 43{\%} and 22{\%}, respectively. A serum alpha-fetoprotein level of 20ng/mL or less was the only factor that was significantly associated with prolonged recurrence-free survival. Of the 12 recurrent nodules in 10 patients, 9 occurred in different segments of the treated lesion and 8 were histopathologically confirmed to be well-differentiated hepatocellular carcinoma. Overall survival rates 1, 3, and 5 years after percutaneous ethanol injection were 100{\%}, 82{\%}, and 75{\%}, respectively. Conclusions: Percutaneous ethanol injection may be useful for the treatment of hepatocellular carcinoma with no tumor stain.",
keywords = "Hepatocellular carcinoma, Liver, Percutaneous ethanol injection, Prognosis, Tumor stain",
author = "H. Ueno and S. Okada and T. Okusaka and M. Ikeda and N. Tanaka and Michiie Sakamoto and M. Yoshimori",
year = "2001",
language = "English",
volume = "48",
pages = "1430--1434",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "41",

}

TY - JOUR

T1 - Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection

AU - Ueno, H.

AU - Okada, S.

AU - Okusaka, T.

AU - Ikeda, M.

AU - Tanaka, N.

AU - Sakamoto, Michiie

AU - Yoshimori, M.

PY - 2001

Y1 - 2001

N2 - Background/Aims: Some hepatocellular carcinoma nodules do not show tumor stain by hepatic angiography or enhanced computed tomography. The aim of this study was to clarify the prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. Methodology: Twenty patients who had hepatocellular carcinoma with no tumor stain were treated by percutaneous ethanol injection between January 1990 and June 1998. No patients had received any anticancer treatments before percutaneous ethanol injection. Recurrence-free survival, predictive factors for recurrence and recurrent patterns were examined. Overall survival was also examined. Results: Ten of the 20 patients showed intrahepatic recurrences in other parts of the treated lesions, although no local recurrence was observed. Median recurrence-free survival time, 1-, 3- and 5-year recurrence-free survival rates were 2.8 years, 66%, 43% and 22%, respectively. A serum alpha-fetoprotein level of 20ng/mL or less was the only factor that was significantly associated with prolonged recurrence-free survival. Of the 12 recurrent nodules in 10 patients, 9 occurred in different segments of the treated lesion and 8 were histopathologically confirmed to be well-differentiated hepatocellular carcinoma. Overall survival rates 1, 3, and 5 years after percutaneous ethanol injection were 100%, 82%, and 75%, respectively. Conclusions: Percutaneous ethanol injection may be useful for the treatment of hepatocellular carcinoma with no tumor stain.

AB - Background/Aims: Some hepatocellular carcinoma nodules do not show tumor stain by hepatic angiography or enhanced computed tomography. The aim of this study was to clarify the prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. Methodology: Twenty patients who had hepatocellular carcinoma with no tumor stain were treated by percutaneous ethanol injection between January 1990 and June 1998. No patients had received any anticancer treatments before percutaneous ethanol injection. Recurrence-free survival, predictive factors for recurrence and recurrent patterns were examined. Overall survival was also examined. Results: Ten of the 20 patients showed intrahepatic recurrences in other parts of the treated lesions, although no local recurrence was observed. Median recurrence-free survival time, 1-, 3- and 5-year recurrence-free survival rates were 2.8 years, 66%, 43% and 22%, respectively. A serum alpha-fetoprotein level of 20ng/mL or less was the only factor that was significantly associated with prolonged recurrence-free survival. Of the 12 recurrent nodules in 10 patients, 9 occurred in different segments of the treated lesion and 8 were histopathologically confirmed to be well-differentiated hepatocellular carcinoma. Overall survival rates 1, 3, and 5 years after percutaneous ethanol injection were 100%, 82%, and 75%, respectively. Conclusions: Percutaneous ethanol injection may be useful for the treatment of hepatocellular carcinoma with no tumor stain.

KW - Hepatocellular carcinoma

KW - Liver

KW - Percutaneous ethanol injection

KW - Prognosis

KW - Tumor stain

UR - http://www.scopus.com/inward/record.url?scp=0034781393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034781393&partnerID=8YFLogxK

M3 - Article

C2 - 11677980

AN - SCOPUS:0034781393

VL - 48

SP - 1430

EP - 1434

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 41

ER -